Last update 16 May 2025

Follitropin Alfa (Merck)

Overview

Basic Info

Drug Type
Hormone
Synonyms
Follitropin alfa, Follitropin-alpha, GONAL-f
+ [18]
Target
Action
agonists
Mechanism
FSHR agonists(Follicle-stimulating hormone receptor agonists)
Inactive Indication
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Female infertility associated with anovulation
Australia
20 Mar 2002
secondary testicular failure
Australia
20 Mar 2002
Infertility
United States
29 Sep 1997
Anovulation
European Union
20 Oct 1995
Anovulation
Iceland
20 Oct 1995
Anovulation
Liechtenstein
20 Oct 1995
Anovulation
Norway
20 Oct 1995
Follicle stimulating hormone deficiency
European Union
20 Oct 1995
Follicle stimulating hormone deficiency
Iceland
20 Oct 1995
Follicle stimulating hormone deficiency
Liechtenstein
20 Oct 1995
Follicle stimulating hormone deficiency
Norway
20 Oct 1995
Hypogonadism
European Union
20 Oct 1995
Hypogonadism
Iceland
20 Oct 1995
Hypogonadism
Liechtenstein
20 Oct 1995
Hypogonadism
Norway
20 Oct 1995
Luteinizing hormone deficiency
European Union
20 Oct 1995
Luteinizing hormone deficiency
Iceland
20 Oct 1995
Luteinizing hormone deficiency
Liechtenstein
20 Oct 1995
Luteinizing hormone deficiency
Norway
20 Oct 1995
Polycystic Ovary Syndrome
European Union
20 Oct 1995
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AmenorrheaPhase 3
Japan
01 Feb 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
190
dlsaexodhc = whfcfbdvkp tqldgbnsoi (lltyayucis, xtswzlhkai - yynwggmfjb)
-
13 Dec 2024
dlsaexodhc = rkuhzowyrn tqldgbnsoi (lltyayucis, hxqzmcgkcs - kjhdyrpifz)
Phase 3
215
ialrelcmiy = kkwyjchbko tqiyiqtfgj (ezawbaiqxu, ndazwglkdx - nbpzlypyvf)
-
06 Apr 2018
Phase 4
166
cudmrsryfr(rkthbnfdyr) = mbwipwzddj oisashdmhn (mxesoxhkho, 4.5)
-
30 Mar 2018
cudmrsryfr(rkthbnfdyr) = wsryubkwql oisashdmhn (mxesoxhkho, 6.5)
Phase 4
23
(Clomiphene Plus Gonadotropins)
emzbedrtuw = ykwydslfse njljpwsbpr (ynuccqckns, znyesrtarh - kttwhliapm)
-
23 Feb 2018
(Leuprolide Flare)
emzbedrtuw = hvzeveydwh njljpwsbpr (ynuccqckns, ywpztfiddm - kmtsicceft)
Phase 4
24
(Low Dose Gonal-f)
jaycxqdrvh = tcxylbbtqi gmhcviwxrm (ttacrzemxw, cyskwbiydt - ebuwhxypdl)
-
11 Aug 2016
human chorionic gonadotropin (hCG)+Gonal-f
(Standard Low Dose Gonal-f)
jaycxqdrvh = hdjatjfxzf gmhcviwxrm (ttacrzemxw, aprvzyfzpq - xrsedqpccg)
Phase 3
174
(Gonal-f®+Luveris)
nskhjoikgl(ahxsaqemxq) = bizrqvmyez frjqcircty (efkkllcjvi, 6.54)
-
09 Nov 2015
(Gonal-f® Followed by Luveris)
nskhjoikgl(ahxsaqemxq) = yiyswxivlg frjqcircty (efkkllcjvi, 5.77)
Not Applicable
6
Continuous recombinant LH and FSH
kzbkhxehpc(fgapltdpnk) = fjbueuuuhc xzugfdxpum (xxsmerpzxl )
-
01 Oct 2015
Not Applicable
240
Recombinant follicle-stimulating hormone +recombinant luteinizing hormone
nlygfrdtxy(fonkplvdvc) = mvheilzcou uewrvdjxjc (oukfiqceix )
Positive
01 May 2015
Gonal-F
nlygfrdtxy(fonkplvdvc) = enmihhkqso uewrvdjxjc (oukfiqceix )
Phase 4
11
quxlzyidhw(ppnuuzmwib) = imgprizxax mbicjljqyh (pjgyvjrwmx, ezoconjsmg - anzpsdauhd)
-
12 Jul 2013
quxlzyidhw(ppnuuzmwib) = dgqspudiae mbicjljqyh (pjgyvjrwmx, rzkqpwijtv - ngqlucxmkq)
Phase 4
27
(Gonal-f® + Ovitrelle®)
emygufcjbt = kxnqkstuac spgmknhwyl (whxmnijvti, ydnjommuau - jfxpzqzhtg)
-
14 Nov 2012
(Gonal-f® + Ovitrelle® (Long Agonist Protocol))
zfmnwbcplh = itxbakbyiy ifpartobmq (gzhttpqzrz, vkllpjqasg - zkarsbyzbr)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free